Trial of Vaccine Therapy in Recurrent Platinum Sensitive Ovarian Cancer Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01334047
Recruitment Status : Terminated (The study needed to be terminated due to new knowledge about cancer vaccines. A new protocol with an expected more efficient vaccine is currently being written.)
First Posted : April 12, 2011
Last Update Posted : August 25, 2014
Information provided by:
Oslo University Hospital

No Study Results Posted on for this Study
  Recruitment Status : Terminated
  Actual Primary Completion Date : August 2013
  Estimated Study Completion Date : April 2022